Enoxaparin Sodium Injection IP 40 mg – Veinova 40 Injection

Enoxaparin Sodium Injection IP 40 mg – Effective and trusted option for the prevention and management of thromboembolic disorders.

Veinova 40 Injection – Enoxaparin 40mg (Pre-filled Syringe) contains Enoxaparin, a low molecular weight heparin (LMWH) that acts as a potent anticoagulant. It works primarily by inhibiting clotting factor Xa, thereby preventing the formation of new clots and limiting the growth of existing ones. Enoxaparin is extensively used for both prophylaxis and treatment of thrombotic conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and in patients undergoing surgery or experiencing reduced mobility.

Recommended by specialists:
✅Cardiologists – For the management of acute coronary syndromes (ACS) and prevention of thrombotic events
✅Vascular Surgeons – For prophylaxis and treatment of DVT and PE, especially around surgical interventions
✅Orthopedic Surgeons – To prevent DVT in patients undergoing joint replacement or major Orthopaedic surgery,.

Key Benefits of Enoxaparin Sodium Injection IP 40 mg – Veinova 40 Injection
✅Consistent Anticoagulant Effect: Provides stable anticoagulation with minimal need for routine monitoring, making it ideal for outpatient management.
✅Enhanced Safety Profile: Lower risk of heparin-induced thrombocytopenia (HIT) compared to conventional heparin, ensuring safer long-term use.
✅Versatile Use: Suitable across a broad spectrum of clinical scenarios—from surgical prophylaxis to treatment of active thromboembolic events.

Indications:
✅Prophylaxis against Deep Vein Thrombosis (DVT)
✅Management of Pulmonary Embolism (PE)
✅Treatment of Acute Coronary Syndrome (ACS)